Medical research

Equine hepatitis viruses help us understand human hepatitis C

More than 70 million people worldwide are infected with hepatitis C. The disease is treatable, but it is often not recognized. In 80% of cases, it takes chronic courses and can lead to liver damage and even liver cancer. ...

Medications

Repurposing FDA-approved drugs may help combat COVID-19

Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...

Diseases, Conditions, Syndromes

Helping the body overcome SARS-CoV-2

As messenger substances, interferons stimulate various responses of immune cells and play a key role in activating the immune system. They are proven active agents against various diseases, especially type I interferon alpha ...

Oncology & Cancer

New risk stratification tool for liver cancer after hepatitis C

Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient ...

page 10 from 40